Fukuoka, Japan

Makoto Tsuda

USPTO Granted Patents = 2 



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Makoto Tsuda: Innovator in Pain Management

Introduction

Makoto Tsuda is a renowned inventor hailing from Fukuoka, Japan, known for his significant contributions to the field of pain management. With a total of two patents to his name, he has focused on developing innovative therapeutic agents to address pain associated with herpes zoster, particularly during its acute phase.

Latest Patents

Tsuda's latest patents include a preventive or therapeutic agent for pain associated with herpes zoster in its acute phase. This agent involves the use of a P2X receptor antagonist, such as paroxetine, which is a diazepinedione derivative. The invention outlines that the compound can be utilized for effectively preventing or treating zoster-associated pain during this critical phase.

Career Highlights

Throughout his career, Makoto Tsuda has worked with esteemed institutions, notably Kyushu University and Nippon Chemiphar Co., Ltd. His research and development efforts have significantly advanced the understanding and management of pain, especially in relation to herpes zoster.

Collaborations

Makoto Tsuda has collaborated with notable colleagues such as Kazuhide Inoue and Yuta Matsumura. These collaborations have enriched his research and have contributed to the successful development of the therapeutic agents he is known for.

Conclusion

As an inventor, Makoto Tsuda's work has not only led to patents but has also paved the way for more effective treatments for patients suffering from herpes zoster. His innovative approaches reflect a deep commitment to improving healthcare outcomes and enhancing the quality of life for individuals affected by pain.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…